About US
Contact us
-
Allergan CEO pooh-poohs investor sniping amid Q2 beat, but analysts aren't so sureThe critics moaning that Allergan’s plan to sell off its women’s health and infectious disease businesses doesn’t go far enough? The activist investors demanding CEO Brent Saunders give up the board2018/7/27
-
Forget a consumer spinoff. GlaxoSmithKline is plotting a $525M cost-cutting drive insteadForget the speculation you’ve heard over the past few days: GlaxoSmithKline is sticking with its three-unit structure, CEO Emma Walmsley told investors Wednesday. And in fact, it’s so committed to t2018/7/26
-
Pfizer building $465M sterile injectables plant at its Michigan sitePfizer has committed to building a massive, $465 million sterile manufacturing plant at its site in Michigan that is expected to add 450 new jobs by the time it is fully operational. Pfizer saidon2018/7/25
-
FDA chief Gottlieb blames drugmakers for ‘anemic’ biosimilar marketThe FDA has so far approved 11 biosimilars, drugs that should be saving patients billions of dollars. But so far, only three of the 11have made it to the market in the U.S., a fact FDA Commissioner2018/7/20
-
Johnson & Johnson softens FDA's Invokana blow with positive kidney resultsJohnson & Johnson has been waiting for its chance to tout Invokana’s cardiovascular benefits for diabetes patients, but thanks to an FDA delay, that won't be happening anytime soon. In the meant2018/7/18
-
Vertex says it's glad England made another offer for CF drugs, but it'll have to do betterVertex CEO Jeffrey Leiden's move earlier this month to pressure England's prime minister Theresa May on drug prices seems to have set some wheels in motion. After negotiations seemingly broke down b2018/7/18
-
FDA joins EU in seeking recall of certain Chinese-made valsartan products over potential cancer riskRecalls of certain drugs containing heart drug valsartan supplied by Zhejiang Huahai Pharmaceutical have spread to the U.S., as the FDA sought voluntary actions to take some affected drugs off the s2018/7/17
-
FDA approves the first drug with an indication for treatment of smallpoxThe U.S. Food and Drug Administration today approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox. Though the World Health Organization declared smallpox, a conta2018/7/16
-
FDA announces voluntary recall of several medicines containing valsartan following detection of an impurityThe U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan, used to treat high b2018/7/16
-
FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactionsThe U.S. Food and Drug Administration today is requiring safety labeling changes for a class of antibiotics called fluoroquinolones to strengthen the warnings about the risks of mental health side eff2018/7/12